stockrowDoximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
Follow DOCS
Alert me
Doximity, Inc. (DOCS) Revenue
Doximity, Inc.'s revenue for fiscal 2026 was $644.9M, up 13.1% from $570.4M in fiscal 2025. Over the twelve months to 30 September 2026 it was $661.6M. Over the past ten years it has ranged from $85.7M (fiscal 2019) to $644.9M (fiscal 2026) — the current reading is the highest in ten years. Revenue has risen for 7 consecutive fiscal years. Doximity, Inc. ranks 13th of 42 Health Information Services companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2026 | $644.9M | 13.05% |
| FY2025 | $570.4M | 19.98% |
| FY2024 | $475.4M | 13.45% |
| FY2023 | $419.1M | 21.98% |
| FY2022 | $343.5M | 66.05% |
| FY2021 | $206.9M | 77.76% |
| FY2020 | $116.4M | 35.82% |
| FY2019 | $85.7M | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $174.5M | 11.44% |
| Jun 2026 | $156.6M | 7.74% |
| Mar 2026 | $145.4M | (21.44%) |
| Dec 2025 | $185.1M | 9.81% |
| 23 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $15.3B |
| PRVA Privia Health Group, Inc. compare | $2.4B |
| TEM Tempus AI, Inc. compare | $1.5B |
| HQY HealthEquity, Inc. compare | $1.4B |
| WAY Waystar Holding Corp. compare | $1.3B |
| HNGE Hinge Health Inc. compare | $720.1M |
| DOCS Doximity, Inc. | $661.6M |
| SDGR Schrodinger, Inc. compare | $269.2M |
| HTFL Heartflow, Inc. compare | $212.1M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on DOCS
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement